New patent expiration for Allergan drug BYSTOLIC

Annual Drug Patent Expirations for BYSTOLIC Bystolic is a drug marketed by Allergan and is included in one NDA. It is available from three suppliers. There is one patent protecting…

The post New patent expiration for Allergan drug BYSTOLIC appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog